tirzepatide and iih Treatment with GLP-1 receptor agonists is associated with significant weight loss favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain FDA approves tirzepatide, Eli Lilly's

Or has the popularity of BPC-157 outpaced the evidence

Studies of SEMA in metabolic liver disease have shown improvement in steatohepatitis with daily administration, but the results have been less satisfactory regarding the improvement of fibrosis at stages F2F3 or F4,30 or with a weekly dose of 2.4 mg over 72 weeks.31 The results of the new phase III ESSENCE trial, evaluating SEMA 2.4 mg over 240 weeks, are highly anticipated

The Telogen Effluvium Connection Your hair grows in cycles

The time courses of weight reduction with ZEPBOUND and placebo from baseline through Week 72 are depicted in Figure 3 for Study 1 and Figure 4 for Study 2

K., Kim, B., Kim, S

What is the gutbrain axis, and how is it connected to the CNS